peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma

Hansa Medical changes certified adviser

24 Nov 2008, 08:00
Regulatory information

As of December 1, 2008, Hansa Medical AB (publ) will change its certified adviser from Kaupthing Bank Sverige AB to Remium AB. The Hansa Medical share is traded on First North under the ticker symbol HMED.For more information, please contact:Emanuel Björne, CEOMobile: +46 707 17 54 77E-mail: emanuel.bjorne@hansamedical.com Henrik Acklén, Remium ABTelephone: +46 8 454 32 00E-mail: henrik.acklen@remium.com